The FDA's Division of Drug Marketing, Advertising and Communication hit Baxter Healthcare Corporation with a warning letter for a physician brochure for Aralast NP, expressing concern over "your continued violative promotion of your products."

Novo Nordisk launched NovoDose, an iPhone app that serves as a mobile insulin dosing guide for physicians, who can look up dosing guidelines and blood glucose levels.

Kimberly-Clark Health Care tapped Schwartz Communications to handle PR for its medical device business.

Eli Lilly said it is halting development of one of two phase III Alzheimer's disease drugs in its pipeline.

Eli Lilly told the state of Indiana that job cuts at its Indianapolis headquarters will be permanent.

Genentech, a member of the Roche Group, will begin voluntarily disclosing data on its independent medical education grants and charitable contributions for the US on August 16, a spokesperson told MM&M.

Grey Healthcare Group (ghg) has acquired Geoff Howe Marketing Communications, an animal health marketing firm with offices in Prague, London and Kansas City.

Pfizer's second-quarter earnings report surprised analysts, with the firm beating EPS consensus by 10 cents on higher revenues and lower expenses.

AstraZeneca experimental blood thinner Brilinta (ticagrelor) got a recommendation from an FDA advisory panel Wednesday.

The loss of marketing exclusivity for its bestseller, blood thinner Lovenox, prompted Sanofi-Aventis to trim its earnings outlook.